Diffuse large B-cell lymphoma: sites of extranodal involvement are a stronger prognostic indicator than number of extranodal sites in the rituximab era.
about
Neutrophil/Lymphocyte Ratio, Lymphocyte/Monocyte Ratio, and Absolute Lymphocyte Count/Absolute Monocyte Count Prognostic Score in Diffuse Large B-Cell Lymphoma: Useful Prognostic Tools in the Rituximab Era.Extranodal involvement in young patients with diffuse large B-cell lymphoma: distribution, prognostic value and treatment options.A new extranodal scoring system based on the prognostically relevant extranodal sites in diffuse large B-cell lymphoma, not otherwise specified treated with chemoimmunotherapy.Validation of the NCCN-IPI for diffuse large B-cell lymphoma (DLBCL): the addition of β2 -microglobulin yields a more accurate GELTAMO-IPI.The Kyoto Prognostic Index for patients with diffuse large B-cell lymphoma in the rituximab era.Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma.Simplicity at the cost of predictive accuracy in diffuse large B-cell lymphoma: a critical assessment of the R-IPI, IPI, and NCCN-IPI.Negative impact of concurrent overexpression of MYC and BCL2 in patients with advanced diffuse large B-cell lymphoma treated with dose-intensified immunochemotherapy.
P2860
Q36194582-489794AB-7D7F-48D5-A119-2250B0441F51Q37697317-DB5BE4A8-30F0-429D-BF68-72026E637165Q39775663-935EAB28-B275-40B9-B9B4-8E08639DB264Q40371971-2BD569A5-F3B5-49A4-A82A-1047A8C8738FQ42553281-62237F7F-727A-4126-B2C8-BA94EBAB00F8Q45530965-ABFC41E1-899D-452C-B13A-C1BA717CCD58Q47312698-F79866F2-5B61-407F-9869-B35BB09D5B73Q48828440-17C92AB7-351B-4B3B-85DA-8B37EAF707B4
P2860
Diffuse large B-cell lymphoma: sites of extranodal involvement are a stronger prognostic indicator than number of extranodal sites in the rituximab era.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Diffuse large B-cell lymphoma: ...... al sites in the rituximab era.
@en
Diffuse large B-cell lymphoma: ...... al sites in the rituximab era.
@nl
type
label
Diffuse large B-cell lymphoma: ...... al sites in the rituximab era.
@en
Diffuse large B-cell lymphoma: ...... al sites in the rituximab era.
@nl
prefLabel
Diffuse large B-cell lymphoma: ...... al sites in the rituximab era.
@en
Diffuse large B-cell lymphoma: ...... al sites in the rituximab era.
@nl
P2093
P2860
P1433
P1476
Diffuse large B-cell lymphoma: ...... al sites in the rituximab era.
@en
P2093
Ching-Liang Ho
Jia-Hong Chen
Ming-Shen Dai
Ping-Ying Chang
Tzu-Chuan Huang
Yeu-Chin Chen
P2860
P304
P356
10.3109/10428194.2014.982636
P577
2015-01-14T00:00:00Z